tradingkey.logo

Intelligent Bio Solutions Inc

INBS
6.230USD
-0.090-1.42%
종가 02/06, 16:00ET시세는 15분 지연됩니다
5.67M시가총액
손실P/E TTM

Intelligent Bio Solutions Inc

6.230
-0.090-1.42%

자세한 내용은 Intelligent Bio Solutions Inc 회사

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc 정보

종목 코드 INBS
회사 이름Intelligent Bio Solutions Inc
상장일Dec 23, 2020
CEOSimeonidis (Harry)
직원 수16
유형Ordinary Share
회계 연도 종료Dec 23
주소135 W 41St St,
도시NEW YORK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호10036
전화16467905756
웹사이트https://ibs.inc/
종목 코드 INBS
상장일Dec 23, 2020
CEOSimeonidis (Harry)

Intelligent Bio Solutions Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
4.04K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
6.00
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
4.04K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
6.00
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United Kingdom
1.07M
96.14%
Rest of world
36.22K
3.26%
Americas
4.97K
0.45%
Australia
1.69K
0.15%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Fri, Jan 30
마지막 업데이트: Fri, Jan 30
주주
주주 유형
주주
주주
비율
Alyeska Investment Group, L.P.
5.54%
Adar1 Capital Management LLC
3.51%
Geode Capital Management, L.L.C.
0.48%
Sakiris (Spiro Kevin)
0.44%
Warberg Asset Management LLC
0.37%
기타
89.66%
주주
주주
비율
Alyeska Investment Group, L.P.
5.54%
Adar1 Capital Management LLC
3.51%
Geode Capital Management, L.L.C.
0.48%
Sakiris (Spiro Kevin)
0.44%
Warberg Asset Management LLC
0.37%
기타
89.66%
주주 유형
주주
비율
Hedge Fund
9.41%
Individual Investor
0.78%
Investment Advisor
0.56%
Investment Advisor/Hedge Fund
0.48%
Research Firm
0.18%
기타
88.59%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
30
129.36K
10.64%
-1.19K
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Alyeska Investment Group, L.P.
67.35K
5.54%
+5.96K
+9.71%
Sep 30, 2025
Adar1 Capital Management LLC
42.64K
3.51%
+42.64K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
5.89K
0.48%
+742.00
+14.42%
Sep 30, 2025
Sakiris (Spiro Kevin)
5.39K
0.44%
--
--
Sep 11, 2025
Warberg Asset Management LLC
4.47K
0.37%
+4.47K
--
Sep 30, 2025
Simeonidis (Harry)
4.04K
0.33%
--
--
Sep 11, 2025
LPL Financial LLC
2.50K
0.21%
+2.50K
--
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.28K
0.11%
--
--
Sep 30, 2025
Citi Investment Research (US)
935.00
0.08%
+935.00
--
Sep 30, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
날짜
배당락일
유형
비율
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
KeyAI